[go: up one dir, main page]

AR113968A1 - Pirrolidinamidas ii sustituidas - Google Patents

Pirrolidinamidas ii sustituidas

Info

Publication number
AR113968A1
AR113968A1 ARP180103706A ARP180103706A AR113968A1 AR 113968 A1 AR113968 A1 AR 113968A1 AR P180103706 A ARP180103706 A AR P180103706A AR P180103706 A ARP180103706 A AR P180103706A AR 113968 A1 AR113968 A1 AR 113968A1
Authority
AR
Argentina
Prior art keywords
alkyl
cycloalkyl
alkylene
aryl
membered heterocycloalkyl
Prior art date
Application number
ARP180103706A
Other languages
English (en)
Inventor
Hennen Stephanie Dr
Friebe Daniela Dr
Schade Markus Dr
Krger Sebastian Dr
Alen Jo Dr
Jakob Florian Dr
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of AR113968A1 publication Critical patent/AR113968A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Reivindicación 1: Un compuesto de acuerdo con la fórmula general (1), donde R¹ representa alquilo-C₁₋₁₀-; cicloalquilo-C₃₋₁₀-; alquileno-C₁₋₆-cicloalquilo-C₃₋₁₀-; heterocicloalquilo de 3 a 7 miembros; alquileno-C₁₋₆-(heterocicloalquilo de 3 a 7 miembros); arilo; alquileno-C₁₋₆-arilo; heteroarilo de 5 ó 6 miembros; o alquileno-C₁₋₆-(heteroarilo de 5 ó 6 miembros); R² representa -C(=O)-alquilo-C₁₋₁₀-; -C(=O)-cicloalquilo-C₃₋₁₀-; -C(=O)-alquileno-C₁₋₆-cicloalquilo-C₃₋₁₀-; -C(=O)-(heterocicloalquilo de 3 a 7 miembros); -C(=O)-alquileno-C₁₋₆-(heterocicloalquilo de 3 a 7 miembros); -C(=O)-arilo; -C(=O)-alquileno-C₁₋₆-arilo; -C(=O)-(heteroarilo de 5 ó 6 miembros); -C(=O)-alquileno-C₁₋₆-(heteroarilo de 5 ó 6 miembros); -S(=O)₁₋₂-alquilo-C₁₋₁₀-; -S(=O)₁₋₂-cicloalquilo-C₃₋₁₀-; -S(=O)₁₋₂-alquileno-C₁₋₆-cicloalquilo-C₃₋₁₀-; -S(=O)₁₋₂-(heterocicloalquilo de 3 a 7 miembros); -S(=O)₁₋₂-alquileno-C₁₋₆-(heterocicloalquilo de 3 a 7 miembros); -S(=O)₁₋₂-arilo; -S(=O)₁₋₂-alquileno-C₁₋₆-arilo; -S(=O)₁₋₂-(heteroarilo de 5 ó 6 miembros); o -S(=O)₁₋₂-alquileno-C₁₋₆-(heteroarilo de 5 ó 6 miembros); R³ representa -alquilo-C₁₋₁₀-; -cicloalquilo-C₃₋₁₀-; -alquileno-C₁₋₆-cicloalquilo-C₃₋₁₀-; arilo; -alquileno-C₁₋₆-arilo; -C(=O)-alquilo-C₁₋₁₀-; -C(=O)-cicloalquilo-C₃₋₁₀-; -C(=O)-alquileno-C₁₋₆-cicloalquilo-C₃₋₁₀-; -C(=O)-arilo; -C(=O)-alquileno-C₁₋₆-arilo; -S(=O)₁₋₂-alquilo-C₁₋₁₀-; -S(=O)₁₋₂-cicloalquilo-C₃₋₁₀-; -S(=O)₁₋₂-alquileno-C₁₋₆-cicloalquilo-C₃₋₁₀-; -S(=O)₁₋₂-arilo; o -S(=O)₁₋₂-alquileno-C₁₋₆-arilo; R⁴ representa -H; -F; -Cl; -Br; -I; -CN; -CH₃; -CF₃; -CF₂H; -CFH₂ o ciclopropilo; X representa N o CR⁵; donde R⁵ representa -H; -F; -Cl; -Br; -I; -CN; alquilo-C₁₋₁₀- o cicloalquilo-C₃₋₁₀-; Y representa N o CR⁶; donde R⁶ representa -H; -F; -Cl; -Br; -I; -CN; alquilo-C₁₋₁₀- o cicloalquilo-C₃₋₁₀-; Z representa N o CR⁷; donde R⁷ representa -H; -F; -Cl; -Br; -I; -CN; alquilo-C₁₋₁₀- o cicloalquilo-C₃₋₁₀-; donde alquilo-C₁₋₁₀-, alquilo-C₁₋₄- y alquileno-C₁₋₆- en cada caso independientemente uno de otro es lineal o ramificado, saturado o insaturado; donde alquilo-C₁₋₁₀-, alquilo-C₁₋₄-, alquileno-C₁₋₆-, cicloalquilo-C₃₋₁₀- y heterocicloalquilo de 3 a 7 miembros en cada caso independientemente uno de otro están no sustituidos o mono o polisustituidos con uno o más sustituyentes que se seleccionan de -F; -Cl; -Br; -I; -CN; alquilo-C₁₋₆-; -CF₃; -CF₂H; -CFH₂; -CF₂Cl; -CFCl₂; -C(=O)-alquilo-C₁₋₆-; -C(=O)-OH; -C(=O)-O-alquilo-C₁₋₆-; -C(=O)-NH₂; -C(=O)-NH(alquilo-C₁₋₆-); -C(=O)-N(alquilo-C₁₋₆-)₂; -OH; =O; -OCF₃; -OCF₂H; -OCFH₂; -OCF₂Cl; -OCFCl₂; -O-alquilo-C₁₋₆-; -O-C(=O)-alquilo-C₁₋₆-; -O-C(=O)-O-alquilo-C₁₋₆-; -O-(CO)-NH(alquilo-C₁₋₆-); -O-C(=O)-N(alquilo-C₁₋₆-)₂; -O-S(=O)₂-NH₂; -O-S(=O)₂-NH(alquilo-C₁₋₆-); -O-S(=O)₂-N(alquilo-C₁₋₆-)₂; -NH₂; -NH(alquilo-C₁₋₆-); -N(alquilo-C₁₋₆-)₂; -NH-C(=O)-alquilo-C₁₋₆-; -NH-C(=O)-O-alquilo-C₁₋₆-; -NH-C(=O)-NH₂; -NH-C(=O)-NH (alquilo-C₁₋₆-); -NH-C(=O)-N(alquilo-C₁₋₆-)₂; -N(alquilo-C₁₋₆-)-C(=O)-alquilo-C₁₋₆-; -N(alquilo-C₁₋₆-)-C(=O)-O-alquilo-C₁₋₆-; -N(alquilo-C₁₋₆-)-C(=O)-NH₂; -N(alquilo-C₁₋₆-)-C(=O)-NH(alquilo-C₁₋₆-); -N(alquilo-C₁₋₆-)-C(=O)-N(alquilo-C₁₋₆-)₂; -NH-S(=O)₂OH; NH-S(=O)₂-alquilo-C₁₋₆-; -NH-S(=O)₂-O-alquilo-C₁₋₆-; -NH-S(=O)₂-NH₂; -NH-S(=O)₂-NH(alquilo-C₁₋₆-); -NH-S(=O)₂-N(alquilo-C₁₋₆-)₂; -N(alquilo-C₁₋₆-)-S(=O)₂-OH; -N(alquilo-C₁₋₆-)-S(=O)₂-alquilo-C₁₋₆-; -N(alquilo-C₁₋₆-) -S(=O)₂-O-alquilo-C₁₋₆-; -N(alquilo-C₁₋₆-)-S(=O)₂-NH₂; -N(alquilo-C₁₋₆-)-S(=O)₂-NH(alquilo-C₁₋₆-); -N(alquilo-C₁₋₆-) -S(=O)₂-N(alquilo-C₁₋₆-)₂; -SCF₃; -SCF₂H; -SCFH₂; -S-alquilo-C₁₋₆-; -S(=O)-alquilo-C₁₋₆-; -S(=O)₂-alquilo-C₁₋₆-; -S(=O)₂-OH; -S(=O)₂-O-alquilo-C₁₋₆-; -S(=O)₂-NH₂; -S(=O)₂-NH(alquilo-C₁₋₆-); -S(=O)₂-N(alquilo-C₁₋₆-)₂; cicloalquilo-C₃₋₆-; heterocicloalquilo de 3 a 6 miembros; fenilo; heteroarilo de 5 ó 6 miembros; -O-cicloalquilo-C₃₋₆-; -O-(heterocicloalquilo de 3 a 6 miembros) ; -O-fenilo; -O-(heteroarilo de 5 ó 6 miembros) ; -C(=O)-cicloalquilo-C₃₋₆-; -C(=O)-(heterocicloalquilo de 3 a 6 miembros); -C(=O)-fenilo; -C(=O)-(heteroarilo de 5 ó 6 miembros); -S(=O)₂-(cicloalquilo-C₃₋₆-); -S(=O)₂-(heterocicloalquilo de 3 a 6 miembros); -S(=O)₂-fenilo o -S(=O)₂-(heteroarilo de 5 ó 6 miembros); donde arilo y heteroarilo de 5 ó 6 miembros en cada caso independientemente uno de otro están no sustituidos o mono o polisustituidos con uno o más sustituyentes que se seleccionan de -F; -Cl; -Br; -I; -CN; alquilo-C₁₋₆-; -CF₃; -CF₂H; -CFH₂; -CF₂Cl; -CFCl₂; alquileno-C₁₋₄-CF₃; alquileno-C₁₋₄-CF₂H; alquileno-C₁₋₄-CFH₂; -C(=O)-alquilo-C₁₋₆-; -C(=O)-OH; -C(=O)-O-alquilo-C₁₋₆-; -C(=O)-NH(OH); -C(=O)-NH₂; -C(=O)-NH(alquilo-C₁₋₆-); -C(=O)-N(alquilo-C₁₋₆-)₂; -OH; =O; -OCF₃; -OCF₂H; -OCFH₂; -OCF₂Cl; -OCFCl₂; -O-alquilo-C₁₋₆-; -O-cicloalquilo-C₃₋₆-; -O-(heterocicloalquilo de 3 a 6 miembros); -NH₂; -NH(alquilo-C₁₋₆-); -N(alquilo-C₁₋₆-)₂; -NH-C(=O)-alquilo-C₁₋₆-; -N(alquilo-C₁₋₆-) -C(=O)-alquilo-C₁₋₆-; -NH-C(=O)-NH₂; -NH-C(=O)-NH(alquilo-C₁₋₆-); -NH-C(=O)-N(alquilo-C₁₋₆-)₂; -N(alquilo-C₁₋₆-)-C(=O)-NH(alquilo-C₁₋₆-); -N(alquilo-C₁₋₆-)-C(=O)-N(alquilo-C₁₋₆-)₂; -NH-S(=O)₂-alquilo-C₁₋₆-; -SCF₃; -S-alquilo-C₁₋₆-; -S(=O)-alquilo-C₁₋₆-; -S(=O)₂-alquilo-C₁₋₆-; -S(=O)₂-NH₂; -S(=O)₂-NH(alquilo-C₁₋₆-); -S(=O)₂-N(alquilo-C₁₋₆-)₂; cicloalquilo-C₁₋₆-; alquileno-C₁₋₄-cicloalquilo-C₃₋₆-; heterocicloalquilo de 3 a 6 miembros; alquileno-C₁₋₄-(heterocicloalquilo de 3 a 6 miembros); fenilo o heteroarilo de 5 ó 6 miembros; en forma del compuesto libre o una sal fisiológicamente aceptable de este.
ARP180103706A 2017-12-18 2018-12-18 Pirrolidinamidas ii sustituidas AR113968A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17208180 2017-12-18

Publications (1)

Publication Number Publication Date
AR113968A1 true AR113968A1 (es) 2020-07-01

Family

ID=60673848

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180103706A AR113968A1 (es) 2017-12-18 2018-12-18 Pirrolidinamidas ii sustituidas

Country Status (14)

Country Link
US (2) US20190185470A1 (es)
EP (1) EP3728233B1 (es)
JP (1) JP2021506965A (es)
CN (1) CN111491931A (es)
AR (1) AR113968A1 (es)
AU (1) AU2018387747A1 (es)
BR (1) BR112020012221A2 (es)
CA (1) CA3085879A1 (es)
EA (1) EA202091428A1 (es)
ES (1) ES2920359T3 (es)
IL (1) IL275375A (es)
MX (1) MX2020006355A (es)
TW (1) TW201927769A (es)
WO (1) WO2019121611A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020006348A (es) 2017-12-18 2020-09-03 Gruenenthal Gmbh Pirrolidinamidas i sustituidas.
MX2021008364A (es) * 2019-01-11 2021-08-05 Gruenenthal Gmbh Amidas de pirrolidina iii sustituidas.
WO2020254551A1 (en) * 2019-06-19 2020-12-24 Grünenthal GmbH Substituted pyrrolidine amides iv
IL298957A (en) * 2020-06-22 2023-02-01 Corcept Therapeutics Inc Quaternary indazole glucocorticoid receptor antagonists
EP4178954B1 (en) * 2020-07-09 2025-11-19 Grünenthal GmbH Substituted pyrrolidine amines and amides as mediator of the glucocortoid receptor
MX2024007586A (es) * 2021-12-21 2024-09-04 Corcept Therapeutics Inc Antagonistas indazólicos bicíclicos del receptor de glucocorticoides.
AU2022417485A1 (en) 2021-12-21 2024-07-04 Corcept Therapeutics Incorporated Piperazine indazole glucocorticoid receptor antagonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006108699A1 (en) * 2005-04-14 2006-10-19 Glaxo Group Limited Indazoles as glucocorticoid receptor ligands
TW200811111A (en) 2006-04-20 2008-03-01 Glaxo Group Ltd Novel compounds
GB0620385D0 (en) 2006-10-13 2006-11-22 Glaxo Group Ltd Novel compounds
TW200829578A (en) * 2006-11-23 2008-07-16 Astrazeneca Ab Chemical compounds 537
JO2754B1 (en) * 2006-12-21 2014-03-15 استرازينكا ايه بي Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
WO2009035067A1 (ja) 2007-09-13 2009-03-19 Santen Pharmaceutical Co., Ltd. １，３，３－トリメチル－７－フェニル－３，４－ジヒドロ－１ｈ－キノキサリン－２－オン誘導体からなるグルココルチコイド受容体アゴニスト
SA109300309B1 (ar) 2008-05-20 2013-01-22 باير شيرنج فارما ايه جي مشتقات فينيل وبنزو داي أوكسينيل إندازول بها استبدال
US9624170B2 (en) * 2013-12-26 2017-04-18 Takeda Pharmaceutical Company Limited 4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors
TW201609693A (zh) * 2014-01-03 2016-03-16 必治妥美雅史谷比公司 雜芳基取代之菸鹼醯胺化合物
ES2751640T3 (es) 2014-09-26 2020-04-01 Astrazeneca Ab Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y uso como moduladores de SGRM
JP2017043614A (ja) 2015-08-25 2017-03-02 参天製薬株式会社 ［４−（１，３，３−トリメチル−２−オキソ−３，４−ジヒドロ−１ｈ−キノキサリン−７−イル）フェノキシ］エチルオキシ化合物またはその塩
US9845314B2 (en) * 2015-09-11 2017-12-19 Boehrnger Ingelheim International Gmbh Pyrazolyl-substituted heteroaryls and their use as medicaments
MX2020006348A (es) * 2017-12-18 2020-09-03 Gruenenthal Gmbh Pirrolidinamidas i sustituidas.

Also Published As

Publication number Publication date
EP3728233B1 (en) 2022-04-20
AU2018387747A1 (en) 2020-08-06
EA202091428A1 (ru) 2020-10-27
IL275375A (en) 2020-07-30
EP3728233A1 (en) 2020-10-28
BR112020012221A2 (pt) 2020-11-24
CA3085879A1 (en) 2019-06-27
US20220127264A1 (en) 2022-04-28
TW201927769A (zh) 2019-07-16
ES2920359T3 (es) 2022-08-03
US20190185470A1 (en) 2019-06-20
MX2020006355A (es) 2020-08-17
WO2019121611A1 (en) 2019-06-27
US12344605B2 (en) 2025-07-01
JP2021506965A (ja) 2021-02-22
CN111491931A (zh) 2020-08-04

Similar Documents

Publication Publication Date Title
AR113968A1 (es) Pirrolidinamidas ii sustituidas
AR113967A1 (es) Pirrolidinamidas i sustituidas
AR117951A1 (es) Derivados de triazolquinoxalina adicionalmente sustituidos
AR112797A1 (es) Inhibidores de kras g12c y métodos para utilizarlos
AR091962A1 (es) Compuesto antidiabeticos triciclicos
ES2682398T3 (es) Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
IT1020162B (it) Altoparlante per la riproduzione di suoni stereofonici a due o a quattro canali
IT995089B (it) Apparecchiatura per la propagazione di cellule per la coltura di tessuti
AR109706A1 (es) INHIBIDORES DUALES DE FOSFATIDILINOSITOL 3 QUINASA d / g
AR101479A1 (es) Derivados de 6-alquinil-piridina
SE7700716L (sv) Prostaglandiner
AR114383A1 (es) Piperidinas o piperidonas sustituidas con urea y fenilo
AR112695A1 (es) Inhibidores de cdpk1, composiciones y métodos relacionados con los mismos
AR111282A1 (es) Inhibidores de cdpk1 ii, composiciones y métodos relacionados con los mismos
AR112463A1 (es) Derivados de propanamina para tratar el dolor y estados relacionados con dolor
AR112233A1 (es) Aminas cíclicas de 6 miembros o lactamas sustituidas con urea y fenilo como moduladores del fpr2
JP1683837S (ja) テープカセット
ES2624379T3 (es) Derivados de heterociclilo y su uso como moduladores del receptor de prostaglandina D2
AR106664A1 (es) Pirazolopiridinaminas sustituidas
AR131633A1 (es) Derivados novedosos de pirimidinil sulfonamida
AR108584A1 (es) 3-oxo-2,6-difenil-2,3-dihidropiridazin-4-carboxamidas
EA202091213A1 (ru) Пептиды для повышения содержания меланина в меланоцитах
AR118405A1 (es) Compuestos inhibidores de ask1 y usos de los mismos
CH75630A (de) Künstlicher Fisch
CL2023002247S1 (es) Cinta sumergible

Legal Events

Date Code Title Description
FB Suspension of granting procedure